Welcome to LookChem.com Sign In|Join Free

CAS

  • or

138730-80-0

Post Buying Request

138730-80-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

138730-80-0 Usage

1H-Indole-2-carboxylic acid, 5-[[(1,1-dimethylethoxy)carbonyl]amino]-, ethyl ester

The chemical name of the compound, also known as Vilazodone.

Potential antidepressant and anxiolytic properties

The compound has the potential to alleviate symptoms of depression and anxiety.

Selective serotonin reuptake inhibitor (SSRI)

Vilazodone selectively inhibits the reuptake of serotonin, a neurotransmitter involved in mood regulation.

Partial agonist of the serotonin 5-HT1A receptor

Vilazodone also acts as a partial agonist of the 5-HT1A receptor, which is involved in mood and anxiety regulation.

Treatment of major depressive disorder and generalized anxiety disorder

Vilazodone is used to treat these mental health conditions.

Increase levels of serotonin in the brain

By inhibiting the reuptake of serotonin and acting as a partial agonist of the 5-HT1A receptor, Vilazodone increases the levels of serotonin in the brain, which helps to improve mood and reduce anxiety.

Ethyl ester form

The compound is in the form of an ethyl ester, which allows for easier absorption and distribution in the body, making it an effective treatment.

Check Digit Verification of cas no

The CAS Registry Mumber 138730-80-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,7,3 and 0 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 138730-80:
(8*1)+(7*3)+(6*8)+(5*7)+(4*3)+(3*0)+(2*8)+(1*0)=140
140 % 10 = 0
So 138730-80-0 is a valid CAS Registry Number.

138730-80-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 5-[(tert-butoxycarbonyl)amino]-1H-indole-2-carboxylate

1.2 Other means of identification

Product number -
Other names 5-tert-Butoxycarbonylamino-1H-indole-2-carboxylic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:138730-80-0 SDS

138730-80-0Relevant articles and documents

Synthesis and preliminary cytotoxicity study of glucuronide derivatives of CC-1065 analogues

Wang, Yuqiang,Yuan, Huiling,Wright, Susan C.,Wang, Hong,Larrick, James W.

, p. 1569 - 1575 (2003)

Glucuronide derivatives of CBI-bearing CC-1065 analogues have been synthesized, and their cytotoxicities tested against U937 leukemia cells. The new compounds show potent antitumor activity in vitro. Compounds 1 and 2, and their corresponding glucuronides

1-(CYCLOALKYL-CARBONYL)PROLINE DERIVATIVE

-

, (2015/06/03)

A compound represented by formula (1) (in the formula: ring-D represents a three- to eight-membered hydrocarbon ring; Ra represents an optionally substituted amino C1-6 alkyl group or the like; Rb1 and Rb2 each independently represent a hydrogen atom, a halogen atom, or the like; Rc represents an optionally substituted C6-10 aryl group or the like; Rd represents a hydrogen atom or the like; and ring-Q represents a (hetero)aryl group or the like which may be substituted with a carboxyl group or the like) or a pharmaceutically acceptable salt thereof exhibits an excellent FXIa inhibitory activity, and is useful as a therapeutic agent against thrombosis or the like.

CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF

-

, (2008/12/08)

The present disclosure provides drug-ligand conjugates that are potent cytotoxins and include a linker between the drug and ligand where the linker has a single amino acid. The disclosure is also directed to compositions containing the drug-ligand conjugates, and to methods of treatment using them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 138730-80-0